Innovation has “created a tailwind for the company that that we haven’t had in a long time,” Medtronic CEO Geoff Martha said at the 2025 J.P. Morgan Healthcare Conference. “These are growth-drivers ...

The Office for Budget Responsibility (OBR) predicts that 3.5 million workers will start paying income tax in 2025/26 as their earnings go above the basic rate threshold of £12,570. Another 400,000 ...

A GIANT 36ft stealth submarine drone dubbed the "Blue Whale" has been deployed in the Baltic Sea to prevent any looming sabotage attacks. Suspicions have been raised over potential deep sea ...

The Samsung Galaxy Tab S8 Ultra is an absolute beast of a device. It's still an amazing tablet that holds its own years later. The 14.6-inch display is as beautiful as it is huge, and the S8 Ultra ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price target of $100.00. Discover outperforming stocks and invest ...

At the 43rd annual J.P. Morgan Healthcare Conference on Monday, Medtronic CEO Geoff Martha mixed in some breaking news with his usual pitch to investors. Just hours earlier, the Centers for ...

Five years ago, Medtronic executives set out to change the company culture and prioritize financial performance alongside innovation. The medtech giant centralized operations to lower costs, brought ...

SAN FRANCISCO—While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now received a European approval for what it describes as ...

Before even leaving stealth mode, Alterya, a startup that uses AI agents to detect fraud, is being acquired by the blockchain giant Chainalysis, Business Insider has learned from multiple sources.

Medtronic has agreed to be the exclusive U.S. distributor of Contego Medical’s portfolio, which includes devices that provide revascularization treatment for carotid and peripheral vascular disease.

Medtronic’s Percept PC neurostimulator with BrainSense technology [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + announced today that it received CE mark approval for its BrainSense ...